Dross
02-05-2007, 01:37 PM
A new story entry has been added:
New Study Seeks Better Outcomes for Kidney Cancer
A new clinical trial at the Ohio State University Medical Center’s James Cancer Hospital and Solove Research Institute will investigate the safety and toxicity of a new combination of drugs for treating kidney cancer.
The phase-I study combines high-dose interleukin-2 with the drug sorafenib and will enroll up to 24 patients.
New Study Seeks Better Outcomes for Kidney Cancer
A new clinical trial at the Ohio State University Medical Center’s James Cancer Hospital and Solove Research Institute will investigate the safety and toxicity of a new combination of drugs for treating kidney cancer.
The phase-I study combines high-dose interleukin-2 with the drug sorafenib and will enroll up to 24 patients.